{"database": "lobbying", "table": "lobbying_activities", "rows": [[2179874, "00c6830d-980b-403f-8da8-83ba31ee71cf", "Q3", "AMERICAN CAPITOL GROUP", 305852, "IPSEN BIOPHARMACEUTICALS, INC.", 2018, "third_quarter", "MMM", "Medicare Part D issues", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2018-10-03T16:19:05.897000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2179874"], "units": {}, "query_ms": 26.615186012350023, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}